Metraipolis › archive › dc_00c4925df8bd

Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO-2b/3 and ALLEGRO-LT Clinical Studies for Alopecia Areata — Europe PMC PMID:41645877

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41645877
DOI
10.1111/1346-8138.70154
License (as archived)
solo-consultazione
Archived
2026-11-06T01:55:50.431Z
SHA-256 of the archived text
d1b1bf5f7147f1acf433df8b8802d368a6e6137da5e6ed06d3fcd0e261214ed9
Stable URL of this page
https://metraipolis.com/documento/dc_00c4925df8bd

How to cite

Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO-2b/3 and ALLEGRO-LT Clinical Studies for Alopecia Areata — Europe PMC PMID:41645877 — Europe PMC (en), https://europepmc.org/article/MED/41645877 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_00c4925df8bd (Metraipolis archive dc_00c4925df8bd, sha256 d1b1bf5f7147f1acf433df8b8802d368a6e6137da5e6ed06d3fcd0e261214ed9)
BibTeX
@misc{dc00c4925df8bd,
  title = {Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO-2b/3 and ALLEGRO-LT Clinical Studies for Alopecia Areata — Europe PMC PMID:41645877},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41645877},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_00c4925df8bd; sha256 d1b1bf5f7147f1acf433df8b8802d368a6e6137da5e6ed06d3fcd0e261214ed9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41645877. Agents can read the archived copy with the MCP tool read_document.